Patients undergoing minimally invasive mitral valve repair or replacement (mini-MVR) have similar outcomes as patients undergoing conventional surgery and also experience shorter hospital stays and ...

NEW YORK CITY -- Heart valve innovation has made polymer valves a reality, with one such device boasting good 1-year outcomes in a small single-arm study. Adults who received the Tria device for ...

Mitral valve prolapse treatment aims to relieve symptoms, prevent complications, and improve the quality of life of people who have blood that leaks back into their heart’s left atrium. Mitral valve ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making it the first minimally invasive, catheter-based treatment that uses a ...

Please provide your email address to receive an email when new articles are posted on . Abbott announced its transcatheter mitral valve replacement system has received a breakthrough device ...

IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...

SAN FRANCISCO, CA—Transcatheter mitral valve replacement (TMVR) with the novel Sapien M3 device (Edwards Lifesciences) is associated with low rates of adverse clinical outcomes and sustained ...

Mitral valve regurgitation is a common heart valve condition in which the mitral valve cannot close properly. Cardiologists may implant mitral valve clips to help the valve close effectively. Mitral ...